Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Stomach Neoplasms 8Colorectal Neoplasms 7Pancreatic Neoplasms 5Ovarian Neoplasms 5Neoplasm Metastasis 5Melanoma 5Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Rectal Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Vaginal Neoplasms 2Sarcoma 2Penile Neoplasms 2Oropharyngeal Neoplasms 2Mesothelioma 2Lung Neoplasms 2Liver Neoplasms 2Hodgkin Disease 2Head and Neck Neoplasms 2Carcinoma, Hepatocellular 2Carcinoma 2Breast Neoplasms 2Anus Neoplasms 2Wilms Tumor 1Turcot syndrome 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1

Interventions

fludarabine 5Cyclophosphamide 5aldesleukin 4fludarabine phosphate 2entinostat 2aflibercept 2Radiotherapy 2Adoptive Transfer 2rocakinogene sifuplasmid 1ripretinib 1pembrolizumab 1oncogene protein E7, Human papillomavirus type 16 1durvalumab 1bintrafusp alfa protein, human 1Vorinostat 1Vaccines, Synthetic 1VGX-3100 1Ritonavir 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1MEDI0457 1Isotretinoin 1Interleukin-2 1Interferon-alpha 1Indinavir 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Penile Neoplasms × fludarabine phosphate × Gastrointestinal × Clear all
NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT02280811 2017-09-06

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
12 enrolled 19 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡